申请人:The Ohio State Research Foundation
公开号:US05919935A1
公开(公告)日:1999-07-06
The present invention relates to novel, halogenated psoralen compounds that are useful for inactivating vital contaminants in blood-derived products, particularly blood-derived products that contain platelets or red blood cells. The psoralen compounds of the present invention have the following formula: The side chain S which is a attached to the carbon at position 8 of the psoralen moiety contains a quartemary ammonium group which comprises a central nitrogen atom, a linking group L, and an aromatic ring structure. The linking group L joins the central nitrogen atom of the quartenary ammonium group to the psoralen moiety. The linking group L comprises a carbon chain having 2 to 12 carbon atoms and an oxygen atom which links the carbon chain to the psoralen moiety. The psoralen compounds of the present invention also comprise one or more halogens attached to the psoralen moiety. Preferably the halogens are attached to the carbon atom at position 3 or 5 of the psoralen moiety. In one class of these novel psoralen compounds, the central nitrogen atom of the quartenary ammonium group is a component of the aromatic ring structure. In another class, the central nitrogen atom is attached to three substituent groups, R.sup.1, R.sup.2, and R.sup.3 wherein R.sup.3 has the following structure: --R.sup.5 --CH.dbd.CH--R.sup.6 wherein R.sup.5 is a carbon chain comprising 1 to 3 carbon atoms, and wherein R.sup.6 is the aromatic ring, The present invention also relates to methods of making and using the novel psoralen compounds.
本发明涉及一种新型的卤代花檬素化合物,该化合物对血液制品中的重要污染物具有灭活作用,特别是对含有血小板或红细胞的血液制品具有作用。本发明的花檬素化合物具有以下结构式:侧链S连接到花檬素部分的第8位碳上,其中包含一个四级铵基,该四级铵基包括一个中心氮原子、一个连接基团L和一个芳香环结构。连接基团L连接四级铵基的中心氮原子与花檬素部分。连接基团L包括一个含有2至12个碳原子的碳链和一个氧原子,将碳链连接到花檬素部分。本发明的花檬素化合物还包括一个或多个连接到花檬素部分的卤素。优选地,这些卤素连接到花檬素部分的第3位或第5位碳原子。在这些新型花檬素化合物的一类中,四级铵基的中心氮原子是芳香环结构的一部分。在另一类中,中心氮原子连接到三个取代基团R.sup.1、R.sup.2和R.sup.3,其中R.sup.3具有以下结构:--R.sup.5--CH.dbd.CH--R.sup.6,其中R.sup.5是一个含有1至3个碳原子的碳链,R.sup.6是芳香环。本发明还涉及制备和使用这种新型花檬素化合物的方法。